Yankui Liu
Overview
Explore the profile of Yankui Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Q, Wang F, Du Y, Liu Y, Zhang Z, Zhang X, et al.
J Cell Mol Med
. 2025 Mar;
29(5):e70444.
PMID: 40079088
Recent research has revealed a close association between obesity and various metabolic disorders, including renal metabolic diseases, but the mechanism is still unknown. This study explored the role of p16INK4a...
2.
Xin W, Yang H, Heng X, Xu T, Zhang K, Zhao Y, et al.
Phytomedicine
. 2025 Mar;
140:156624.
PMID: 40068294
Background: Doxorubicin (Dox)-induced cardiomyopathy (DIC) is characterized by severe myocardial damage that can progress to dilated cardiomyopathy and potentially lead to heart failure. No effective prevention or treatment strategies are...
3.
Liu H, Li G, Shen C, Qi X, Liu Y, Hua D, et al.
Biochim Biophys Acta Mol Basis Dis
. 2025 Mar;
1871(5):167771.
PMID: 40057208
Colorectal cancer (CRC) is the second‑leading cause of cancer-related mortality worldwide. It is frequently characterized by chemotherapy resistance，which is a predominant factor contributing to unfavorable patient prognosis. B7-H3 is a...
4.
Wang F, Li J, Zhang Z, Huang G, Zhang X, Liu Q, et al.
Tissue Cell
. 2025 Feb;
94:102795.
PMID: 39987774
Baicalin has garnered attention for its potential therapeutic effects on various cardiovascular conditions, including drug-induced cardiac injury. In this study, we utilized a murine model to explore the protective role...
5.
Liu Y, Chen A, Wu Y, Ni J, Wang R, Mao Y, et al.
Cell Death Dis
. 2025 Feb;
16(1):70.
PMID: 39910035
We here investigate the expression of the mitochondrial carrier homolog 2 (MTCH2) and its potential function in castration-resistant prostate cancer (CRPC). Bioinformatic analyses reveal that MTCH2 overexpression is associated with...
6.
Li H, Du R, Xiang A, Liu Y, Guan M, He H
FASEB J
. 2024 Nov;
38(23):e70042.
PMID: 39614664
As a common digestive disease, acute pancreatitis (AP) often threatens the life of patients. Bone marrow mesenchymal stem cells (BMSCs) derived exosomes have exhibited some benefits for AP. However, the...
7.
Liu Y, Li Y, Wang R, Chen S, Sun N, Qi X
BMC Biotechnol
. 2024 Oct;
24(1):77.
PMID: 39385151
Background: Homocysteine (HCY) is a sulfur-containing amino acid that is an independent or important risk factor for the occurrence of many chronic diseases and is one of the most important...
8.
Wu S, Zhang J, Chen S, Zhou X, Liu Y, Hua H, et al.
Ann Hematol
. 2024 Jun;
103(8):2877-2892.
PMID: 38842567
Diffuse large B-cell lymphoma (DLBCL) represents the most common tumor in non-Hodgkin's lymphoma. N-Myc downstream-regulated gene 2 (NDRG2) is a tumor suppressor highly expressed in healthy tissues but downregulated in...
9.
Hua Y, Wang R, Liu Y, Liu Q, Qi X, Ding Y, et al.
J Sep Sci
. 2024 May;
47(11):e2400164.
PMID: 38819794
Oxaliplatin (L-OHP), a third-generation platinum-based anti-tumor drug, finds widespread application in the first-line treatment of metastatic colorectal cancer. Despite its efficacy, the drug's usage is curtailed by a litany of...
10.
Zhang T, He Z, Qi X, Zhang Y, Liu Y, Jin L, et al.
J Cancer
. 2024 May;
15(11):3441-3451.
PMID: 38817851
Chemoresistance is a key reason for treatment failure in colorectal cancer (CRC) patients. The tumor microenvironment of chemoresistant CRC is distinctly immunosuppressive, although the underlying mechanisms are unclear. The CRC...